EcoDrugPlus

Membrane Metalloendopeptidase

Ensembl ID : ENSATEG00000015614
Gene Symbol: MME
3 Cross references
234 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSATEG00000022567
Gene Symbol: METAP2
4 Cross references
229 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSATEG00000007189
Gene Symbol: MAPK1
3 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSATEG00000016053
Gene Symbol: MAPK10
1 Cross references
221 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSATEG00000005369
Gene Symbol: MAPK11
2 Cross references
200 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSATEG00000004831
Gene Symbol: MAPK3
3 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase 8a

Ensembl ID : ENSATEG00000022510
Gene Symbol: MAPK8A
3 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 8b

Ensembl ID : ENSATEG00000005885
Gene Symbol: MAPK8B
3 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 1

Ensembl ID : ENSATEG00000009613
Gene Symbol: MAP2K1
3 Cross references
215 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 2a

Ensembl ID : ENSATEG00000024201
Gene Symbol: MAP2K2A
3 Cross references
218 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 2b

Ensembl ID : ENSATEG00000015486
Gene Symbol: MAP2K2B
3 Cross references
202 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 10

Ensembl ID : ENSATEG00000013453
Gene Symbol: MAP3K10
2 Cross references
183 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).